Answers are grounded in this paper and cite their sources.
Bacterial infections are one of the most serious health risks worldwide, and their rapid diagnosis remains a major challenge in clinic. To enhance the relaxivity and bacterial specificity of magnetic resonance imaging (MRI) contrast agents, here, a kind of gadolinium-based nanoparticles (NPs) of impressive biocompatibility is constructed as a contrast agent for maltodextrin-mediated bacteria-targeted diagnosis. To realize this, positively charged ultrasmall gadolinium oxide (Gd 2 O 3, 2–3 nm) NPs are embedded in mesoporous silica NPs (MSN) with pore size around 6.38 nm. The resulting Gd 2 O 3 @MSN exhibits enhanced r 1 value and T 1 -weighted MRI performance. Interestingly, upon conjugation of Gd 2 O 3 @MSN with maltodextrin to produce Gd 2 O 3 @MSN-Malt NPs, a remarkable decrease in internalization by osteosarcoma cells, alongside an increased adsorption toward E. coli and S. aureus, is achieved. It is therefore conceivable that the bacteria-targeted Gd 2 O 3 @MSN-Malt might be a promising MRI contrast agent for effective discrimination of bacterial infections from tumor.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: